5. Expand and bolster government and industry engagement with international partners on policy and regulatory environment for enabling the 5G technology ecosystem: Prioritize the removal and reduction of regulations by partners that create barriers to trade and market access issues for United States technology companies. Work with partners, including through the development of information products on 5G policy and regulatory framework, to advance policies that help expand business opportunities for United States technology vendors. Policies such as strong intellectual property protection, best practices on conformity assessment procedures, acceptance of industrydriven standards, risk-based cybersecurity principals, and free flow of cross-border data are some of the key policy enablers. 6. Enhance and expand bilateral and multilateral assistance programs with like-minded countries and trading partners to promote the deployment of digital innovations for communications infrastructure: Leverage expertise from across United States Government departments and agencies, academia, United States industry, and knowledge leaders from trusted like-minded partners to develop capacity building, workforce development, and other programs to foster the deployment and commercialization of digital technology innovations for 5G and next-generation networks and services. Develop funding mechanisms to accelerate the replacement of untrusted vendors in partners' telecommunications infrastructure, considering gaps in the existing authorities of the Export-Import Bank and Development Finance Corporation as well as the potential need for a dedicated fund. 7. Metrics to track the progress and accomplishment of strategic framework objectives include: completed commercial deals for United States companies, selection of other trusted vendors for technology procurements, trade barriers reduced or removed, relevant bilateral or multilateral engagements, number of trade missions and workshops completed, and level of United States private sector and academic participation in demonstration and test bed trials. 39

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents